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A B S T R A C T
Apolipoprotein (a) is a component of lipoprotein (a). Several studies have shown the
association between risk of coronary heart diseases and the size of apo(a) isoforms, al-
though this issue is still controversial. Recent researches focused the attention on the
pentanucleotide (TTTTA), highlighting a statistical correlation between low Lp(a) lev-
els and high repeat numbers. In the present paper we studied the distribution of the
apo(a) pentanucleotide polymorphism among populations from Corsica, and we then
compared it with other populations from Europe, Africa and Asia. The results stressed
out the usefulness of these markers in population genetics analysis. We later investi-
gated the possible association of the apo(a) pentanucleotide polymorphism with serum
lipid levels in two samples from Corsica (France): one comprises patients or individuals
with high risk of future coronary heart disease and the other is a control sample. No sig-
nificant differences between the two groups have been found, but the analysis of vari-
ance showed a significant association between different genotypes and cholesterol and
LDL serum levels.
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Introduction
In previous studies different authors
had highlighted an association between
VNTR and restriction sites of the Apo-
lipoprotein genes (ApoE, ApoC, ApoB)
and lipid levels and thus with the risk in
determining cardiovascular disease1–4,
but sometimes controversial results were
obtained5. In a previous work6, we ana-
lyzed Apolipoprotein E and C, besides the
VNTR ApoB, the restriction sites XbaI
and EcoRI and the locus ins/del, located
in the ApoB gene. These studies under-
lined a significant association only in the
control sample between HDL levels and
ApoCII and ApoB XbaI genotypes, and
moreover between LDL levels and ApoE
and ApoB XbaI genotypes.
In the present study we investigated
the distribution of the pentanucleotide
apo(a) in three samples from the general
population of Corsica and the possible as-
sociation of the pentanucleotide repeat
polymorphism (TTTTA) of apo(a) with se-
rum lipid levels in the Corsican sample of
Corte.
Apolipoprotein (a) is a component of li-
poprotein (a) and it is molecularly homol-
ogous to plasminogen. It is well known
that the level of Lp (a) is an independent
risk factor for cardiovascular disease, and
it is genetically determined. Numerous
studies have shown the association be-
tween risk of coronary heart disease and
the size of apo(a) isoforms, although this
issue is still controversial. Recent resear-
ches concentrated on the pentanucleotide
(TTTTA), located 1.3 kb upstream of the
first exon in the apo(a) gene (chromosome
6, 6q26–q27). These studies highlighted a
statistical correlation between low Lp(a)
levels and high repeat numbers7–9.
The aims of this study are essentially
two: a) to analyze the distribution of
apo(a) frequencies in order to verify their
usefulness as markers in population ge-
netic studies, and b) to estimate if differ-
ent apo(a) genotypes or alleles could in-
fluence the plasma lipid levels.
Materials and Methods
Three Corsican samples (France) from
Bonifacio (southern Corsica, n = 48), Cor-
te (central Corsica, n = 99) and Balagna
(northern Corsica, n = 50) have been ana-
lyzed (Figure 1).
Corsica is the 3rd island in the western
Mediterranean Basin. The density at the
present day is 28.8 inhabitants per km2.
Corsica has experienced a high degree of
isolation as suggested by its geomorpho-
logic characteristics, its small villages (of-
ten less than 400 inhabitants), the uni-
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Fig. 1. Geographical position of the analyzed
Corsican populations.
queness of its gene frequencies for some
polymorphism and a strong genetic heter-
ogeneity with respect to other Mediterra-
nean populations10,11.
The sample of Corte is divided into
two groups. Both of them comprehend
unrelated individuals, born and lived in
the same area for at least three genera-
tions. The first group is formed by 52 in-
dividuals (22 males and 30 females) af-
fected by cardiovascular diseases (myo-
cardial infarction or hypertension) or with
high risk for those diseases, with an aver-
age age of 58 years. The risk factor has
been determinated considering triglycer-
ides levels, total cholesterol/HDL ratio,
ApoA/ApoB ratio, as they have been pro-
ved to be the best indicators as risk fac-
tors for cardiovascular diseases12,13. The
second group is a control sample, consti-
tuted by 47 healthy individuals (21 males
and 26 females) that do not show any risk
factor for cardiovascular disease, with an
average age of 56 years. We use only this
group for the first purpose of the present
work.
Blood samples were collected at Uni-
versity of Corsica (Corte). Lipid levels of
the patients group from Corte were de-
terminated with the standard techniques
at an analysis laboratory of Corte, by one
of us (M. Memmi). Cholesterol and tri-
glycerides levels were determinated us-
ing enzymatic methods, HDL cholesterol
was measured in the supernatant after
precipitation of other lipoproteins with
MgCl2, ApoA and ApoB were quantified
by immunoturbidimetry. VLDL was mea-
sured with density-gradient ultracentri-
fugation, LDL cholesterol was subse-
quently calculated using the formula of
Friedewald et al.14, the diagnosis and the
risk factor were determinated by medical
doctors from Corte following the standard
procedures. Then, all the blood samples
were taken to the Department of Experi-
mental Biology of Cagliari University,
where they were analyzed.
DNA was extracted from whole blood
by the phenol-chloroform standard tech-
nique, and then it was amplified using
the following primers:
5’ – GAA TTC ATT TGC GGA AAG ATT G – 3’
5’ – CTT CAA CCG GGG TGA GAG TCT C – 3’
The amplified fragments were then
separated through a poliacrylamide gel
and colored with Ethidium bromide.
Genepop program (version 2.1) was
used to calculate the allele frequencies,
the Hardy-Weinberg equilibrium and the
heterozygosity values. The deviation from
Hardy-Weinberg equilibrium was tested
by Markov chain, carried out in accor-
dance with Guo and Thompson15. Gene-
pop Program was also used to estimate
the differentiation among the samples,
using the exact Fisher test, with the Mar-
kov chain method.
The healthy Corsican sample was com-
pared with our personal data and others
obtained from literature to verify the use-
fulness of this marker in population anal-
ysis. The comparison was made by study-
ing the genetic distances, using Nei me-
thod16. A dendrogram was built from the
matrix of the distances using the UPGMA
method. Both these analysis were elabo-
rated using Phylip 3.5c program17.
Besides, the spatial autocorrelation
coefficient (I of Moran) was calculated,
using the program SAAP (version 4.3).
This analysis shows a possible associa-
tion between genetic and geographic dis-
tances. The significant of each correlation
was tested using Bonferroni test18.
Possible associations between genoty-
pes and lipid levels have been estimated
with variance analysis (ANOVA), using
Statistica program. The relative risk and
the odds ratio were calculate through the
Epi Info 6 program (version 6.04b)
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Results
Table 1 shows the allele frequencies,
the product lengths and the p-value for
the Hardy-Weinberg equilibrium of pen-
tanucleotide apo(a) in the three Corsican
samples. All the samples except Balagna
meet the Hardy-Weinberg equilibrium. We
totally found 6 alleles. The allele frequen-
cies distribution is bimodal for all the
samples, with pick on alleles 8 and 10 for
the samples from Corte and Balagna, Bo-
nifacio shows the pick on alleles 6 and 8.
A certain degree of internal variability
was detected in Corsica, in fact, the com-
parison Balagna-Bonifacio, carried on
with the Fisher test, shows significant
value (p=0.047). Corsican allele frequen-
cies were compared with data from the
other two Mediterranean islands: Sardi-
nia and Sicily. The Sardinian samples
came from Southern Sardinia, Nuoro
area (central) and Gallura area (north-
ern), the Sicilian samples were from Tra-
pani and Palermo areas.
Variability among the islands was tes-
ted with Fisher’s test. Results showed
significant values, demonstrating a strong
heterogeneity between Sardinia and Si-
cily (p=0.008) and between Sicily and
Corsica (p= 0.003), whereas Sardinia and
Corsica did not appear statistically heter-
ogeneous (p= 0.09).
Corsican samples were compared with
several other samples from different coun-
try19–21, calculating the genetic distances.
In Table 2 Nei distances are showed.
The greatest distance is between Japan
and Balagna (0.0647) whereas the minor
one is between Southern Sardinia and
Nuoro (0.0001). The tree obtained from
the distances matrix with UPGMA me-
thod (Figure 2) shows three principal
clusters. China and Japan populations
constitute the first cluster, and a second
one is formed by Morocco and Southern
Africa. The third cluster, split into two
branches, groups all the European popu-
lations. In one branch we find the popula-
tions from Northern Iberian Peninsula
and Central-northern Europe, on the
other populations from the islands of Cor-
sica, Sicily, Sardinia and Central-north-
ern Spain are located. Some populations
occupy abnormal positions: Corsican pop-
ulation from Balagna is located on an iso-
lated branch, out of the Euro-Mediterra-
nean populations cluster, and the Sicilian
population of Alia is associated with the
Iberian Peninsula and Continental Eu-
rope. This comes as a surprise, since it
should be on a different cluster, where
the other Sicilian population of Trapani is
located.
Spatial autocorrelation analysis sho-
wed significant values for alleles 7, 10
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TABLE 1
ALLELE FREQUENCIES, PRODUCT LENGHTS AND HARDY-WEINBERG EQUILIBRIUM




Corte (patients) Corte (healthy) Bonifacio Balagna
6 86 0.010 0 0.010 0
7 91 0.020 0 0 0
8 96 0.776 0.777 0.719 0.680
9 101 0.082 0.064 0.115 0.080
10 106 0.112 0.149 0.104 0.230
11 111 0 0.011 0.052 0.010
HW (p-value) 0.532 1 0.117 0.005
109






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































and 11 (Table 3). In Figure 3 correlo-
grams of those alleles are showed. The
correlogram of allele 7 describes a re-
gional patchy, whereas the correlograms
of alleles 10, 11 and the one obtained by
the average values of the all alleles ex-
plain a long distance differentiation.
As far as the second purpose of the
present study is concerned, the sample
formed by individuals affected or with
high risk for cardiovascular diseases was
compared with the control sample of
Corte. Few differences in the allele fre-
quencies distribution have been found.
The patient group shows a major number
of alleles and alleles with shorter size
(Table 1). However, the two samples are
not statistically different.
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Fig. 2. Genetic tree drawn through UPGMA method.
TABLE 3
I OF MORAN VALUES AND ITS SIGNIFICANCE
552 977 1186 1659 2888 8388 13550 p
Apo(a)*7 –0.03 0.04 0.06 0.05 0.03 –0.42** –0.08 0.009**
Apo(a)*8 0.02 –0.05 –0.22 –0.04 –0.05 0.02 –0.02 0.696
Apo(a)*9 0.03 –0.01 –0.30* 0.02 –0.04 –0.03 –0.01 0.214
Apo(a)*10 0.26* –0.14 –0.05 0.05 –0.05 0.12 –0.54** 0.001**
Apo(a)*11 –0.20 0.19 0.05 0.01 0.11 0.36* –0.16 0.039*
Average 0.02 0.00 –0.09 0.02 0.00 –0.13 –0.16
* p<0.05; ** p<0.01
Odds ratio (OR) and relative risk (RR)
were calculated for each genotype, to es-
tablish if a certain genotype could repre-
sent a risk factor for cardiovascular dis-
ease, but neither OR or RR values re-
sulted significant. On the contrary, when
allele frequencies are considered, differ-
ent results came out. Alleles 6 and 7 have
a relative risk of 2.01 and 2.02 respec-
tively, both with a p value <0.05. It was
not possible calculating the RR for allele
11 since it is absent in the patients group,
but odds ratio resulted zero and the p
value was 0.0009. These results, how-
ever, are not final and must be inter-
preted cautiously, because of the low
number of individuals carrying these al-
leles. Before analyzing the effect of geno-
type on plasma lipid levels, we verified if
the lipid levels in the two samples were
statistically different. Through Statistica
package t-test was applied to the average
values of the lipids (total cholesterol, tri-
glycerides, HDL, LDL, VLDL, ApoA and
ApoB). In each case, except for HDL, the
average values are greater in the patients
than in the control sample. The p value
appeared significant in all cases except in
HDL, confirming the differences between
the two samples.
Table 4 shows the average values of
plasma lipids in the different genotypes
both in patients, in the control group and
in the total sample. Variance analysis has
been applied to test if the observed differ-
ences were statistically significant. We
only found significant correlation be-
tween genotypes and total cholesterol le-
vels in the patients group, and between
genotypes and LDL in the control group.
Considering the total sample, only the
value related to total cholesterol appea-
red significant.
But since some genotype are presen-
ted only by one or two individuals, we
preferred excluding those genotypes, so
only the three common Apo(a) genotypes
8–8, 8–9 and 8–10 are included in the
analysis, as suggested by Bo21. In this
case just total cholesterol and LDL levels
presented significant association with
apo(a) genotypes in the control sample.
Precisely 8–10 genotype presented the
lowest values and 8–9 genotype the great-
est values of total cholesterol and LDL.
Discussion
Pentanucleotide (TTTTA) in the apo(a)
gene has not been employed yet in re-
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Apo(a)*7 Apo(a)*10
Apo(a)*11 Average
Fig. 3. Correlograms of the alleles with I of Moran significant values.
search on population genetics before now.
In this work the variability of the com-
mon pentanucleotide repeat polymorphism
in three samples from Northern, Central
and Southern Corsica (France) is showed.
This polymorphism probably evolved by
duplication or by slippage mutation dur-
ing DNA replication, as suggested for
other repetition sequences in the human
genome22.
Differentiation test between the is-
lands stressed out a strong heterogeneity
between Sicily and Sardinia and between
Sicily and Corsica, whereas Sardinia and
Corsica did not appear differentiated. This
result is confirmed by historical and ar-
chaeological data that indicate close rela-
tionship between the two islands that
during the Quaternary formed a single
block. This result has been also confirmed
by other papers on classical and DNA
markers10,23,24.
Genetic tree highlighted that apo(a)
pentanucleotide can discriminate popula-
tions belonging to different continents. In
fact, Asian and African populations ap-
pear clearly differentiated from the Euro-
pean ones. Moreover, the populations
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TABLE 4
AVERAGE VALUES FOR LIPIDS IN THE TOTAL, CONTROL AND PATIENTS SAMPLES FOR EACH
GENOTYPE (LIPID VALUES ARE EXPRESSED IN MG/DL)
Total
Genotype N Chole-sterol HDL LDL
Trigly-
cerides VLDL ApoA ApoB
6–7 1 267.0 55.0 180.0 160.0 32.0 172.0 154.0
7–8 2 278.0 55.5 170.5 261.0 52.0 177.5 153.5
8–8 56 237.7 47.7 155.7 168.5 33.7 147.6 128.9
8–9 13 244.6 49.0 156.5 185.7 39.1 156.6 125.6
8–10 20 225.2 52.3 144.0 145.0 29.1 139.6 118.9
8–11 1 189.0 46.0 123.0 102.0 20.0 112.0 74.0
9–10 1 395.0 64.0 297.0 172.0 34.0 194.0 173.0
10–10 2 203.5 39.5 145.0 95.0 19.0 147.0 104.5
Control
Genotype N Chole-sterol HDL LDL
Trigly-
cerides VLDL ApoA ApoB
8–8 28 208.8 49.6 137.9 103.3 20.8 140.1 100.6
8–9 6 218.0 48.0 145.8 99.8 24.2 147.2 94.3
8–10 10 180.6 52.7 108.3 97.7 19.6 125.4 91.4
8–11 1 189.0 46.0 123.0 102.0 20.0 112.0 74.0
10–10 2 203.5 39.5 145.0 95.0 19.0 147.0 104.5
Patients
Genotype N Chole-sterol HDL LDL
Trigly-
cerides VLDL ApoA ApoB
6–7 1 267.0 55.0 180.0 160.0 32.0 172.0 154.0
7–8 2 278.0 55.5 170.5 261.0 52.0 177.5 153.5
8–8 28 266.5 45.9 173.6 233.7 46.6 155.1 157.2
8–9 7 267.4 50.0 165.6 259.3 51.8 164.7 152.4
8–10 10 269.8 52.0 179.8 192.4 38.6 153.9 146.4
9–10 1 395.0 64.0 297.0 172.0 34.0 194.0 173.0
from the three Mediterranean islands ap-
pear always part of a single cluster. The
peculiar position of Balagna population,
stressed out by several statistical analy-
sis, does not surprise, because a previous
paper had underlined the genetic differ-
entiation of this population in respect
both of the other Corsicans and Euro-Me-
diterranean populations24. The genetic
differentiation could be explained with
the isolation of Balagna population: this,
in turn, is probably due to the geographic
location of Balagna, whose isolation is
demonstrated, in fact, by its very low rate
of exogamic marriages25. The Sicilian po-
pulations from Alia and Trapani did not
resulted associated, and this bears wit-
ness to their genetic differentiation. This
differentiation can be a consequence of
genetic drift that acted on genetic struc-
ture of Alia population, and that was fur-
thermore favored by isolation and bottle-
neck events due to cholera epidemics26.
The general allele frequencies distri-
bution of pentanucleotide apo(a) seems to
be influenced by geographical phenome-
non, as spatial autocorrelation analysis
showed.
As far the possible associations be-
tween genotypes and plasma lipid levels,
our data give controversial results. In
fact, we did not found a statistical differ-
entiation between the patients and the
control group, neither for genotype or al-
lele frequencies, and also the relative risk
test did not point out any genotype as fac-
tor predisposing to cardiovascular disea-
se. Genotype distribution appears quite
similar in the healthy individuals and the
ones affected by cardiovascular diseases.
With further analysis applied on allele
frequencies, as suggested by other au-
thor7,8, allele 6 and 7 appear as possible
risk factor, and allele 11 could represent a
protection factor for those pathologies.
This is confirmed by the absence of the
shortest alleles in our control group and
the absence of the allele 11 in patients
group we analyzed. This result is in ac-
cordance with other papers that demon-
strated an association between higher
numbers of repeats and lower Lp(a) lev-
els, and so with low risk of contracting
cardiovascular diseases9,27,28.
Finally, variance analysis stressed out,
in the control sample, an association be-
tween total cholesterol and LDL low levels
and HDL high levels and 8–10 genotype,
as though it represented a protection fac-
tor. This association assumes a great im-
portance. LDL has been calculated ac-
cording with Friedwald14 and following
this method, Lp(a) levels are included in
LDL values, so this relation could be in-
terpreted also as an association between
Lp(a) levels and (TTTTA) apo(a) geno-
types.
Therefore our research lead to the con-
clusion that if, on one hand, a certain de-
gree of association between plasma lipid
levels and genotypes is undoubted, we did
not claim certainly that a particular
apo(a) genotype can represent a risk fac-
tor in determining cardiovascular disea-
se, as other authors suggested21,28. The
negative effects of alleles with a low num-
ber of tandem repeats, pointed out by pre-
vious works, seem been confirmed in this
study. However, the relationship between
apo(a) genotypes and cardiovascular dis-
ease could be further clarified by a re-
search relying on more samples.
In conclusion, pentanucleotide apo(a)
turned out to be extremely useful for the
analysis of micro and macro geographical
variability, as suggested by other au-
thors9,29, but we can not be sure that it
could have a direct influence in determin-
ing cardiovascular disease. The contro-
versial results obtained on this subject by
different authors and confirmed in the
present paper could be due to the pres-
ence of genetic differences between popu-
lations, as De Knijff had suggested to ex-
plain analogous controversy on ApoE ge-
ne30, and they could be clarified through
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the haplotype analysis of Apolipoprotein
loci, that we are carrying on.
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PENTANUKLEOTIDNI PONAVLJAJU]I POLIMORFIZAM (TTTTA) U
APOLIPOPROTEIN (A) GENU: RASPROSTRANJENOST I POVEZANOST
S RIZIKOM OBOLIJEVANJA OD KARDIOVASKULARNIH BOLESTI
S A @ E T A K
Apolipoprotein (a) je komponenta lipoproteina (a). Nekoliko studija je pokazalo po-
vezanost izme|u rizika obolijevanja od koronarne bolesti srca i veli~ine apo(a) izofor-
ma, premda je ovaj nalaz jo{ predmetom kontroverzi. U `ari{tu pa`nje novijih istra`i-
vanja je pentanukleotid (TTTTA), koji poja{njava statisti~ki zna~ajnu korelaciju izme-
|u niske razine Lp(a) i velikog broja ponavljaju}ih jedinica. U ovom radu istra`uje se
raspodjela polimorfizama apo(a) pentanukleotida me|u populacijama iz Korzike, te je
potom ona uspore|ena s drugim populacijama iz Europe, Afrike i Azije. Rezultati na-
gla{avaju korisnost ovog biljega u populacijsko-geneti~kim analizama. Potom je istra-
`ivana mogu}a povezanost polimorfizma apo(a) pentanukleotida s razinom serumskih
lipida u dva uzorka iz Korzike (Francuska): jedan su sa~injavali bolesnici i osobe s
visokim rizikom od razvoja koronarne bolesti srca, a drugi uzorak je bio kontrolna sku-
pina. Dvije skupine nisu se zna~ajno razlikovale no analiza varijance pokazala je zna-
~ajnu povezanost izme|u razli~itih genotipova i razine kolesterola i LDL u serumu.
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